Package 72888-079-17

{"route": ["ORAL"], "spl_id": "44a068c2-5fbc-6667-e063-6394a90a3569", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "upc": ["0372888079172"], "unii": ["X4HES1O11F"], "rxcui": ["307730"], "spl_set_id": ["6a9ea291-4ad5-48a8-8c08-5a17c8757549"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Advagen Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "473 mL in 1 BOTTLE (72888-079-17)", "package_ndc": "72888-079-17", "marketing_start_date": "20210109"}], "brand_name": "Acyclovir", "product_id": "72888-079_44a068c2-5fbc-6667-e063-6394a90a3569", "dosage_form": "SUSPENSION", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "72888-079", "generic_name": "Acyclovir", "labeler_name": "Advagen Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "200 mg/5mL"}], "application_number": "ANDA215724", "marketing_category": "ANDA", "marketing_start_date": "20210109", "listing_expiration_date": "20261231"}